1,151
Views
1
CrossRef citations to date
0
Altmetric
Bedside to Bench Report

Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications

, , , , , , , & show all
Pages 1439-1443 | Received 11 Jun 2014, Accepted 16 Aug 2014, Published online: 16 Dec 2014

References

  • Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev 2008; 34:193-205; PMID:18313224; http://dx.doi.org/10.1016/j.ctrv.2007.12.001
  • Centre M, Jemal A, Smith R, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59:366-78; PMID:19897840; http://dx.doi.org/10.3322/caac.20038
  • Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, et al. Sarcomatoid renal cell carcinoma: An examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 2004; 28:435-41; PMID:15087662; http://dx.doi.org/10.1097/00000478-200404000-00002
  • Farrow GM, Harrison EG Jr, Utz DC. Sarcomas and mixed malignant tumors of the kidney in adults. Part III. Cancer 1968; 22: 556-63; PMID:4299778; http://dx.doi.org/10.1002/1097-0142(196809)22:3<556::AID-CNCR2820220310I>3.0.CO;2-N
  • DeLong W, Grignon DJ, Eberwein P, Shum DT, Wyatt JK. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med 1993; 117:636-40. 5; PMID:7684893
  • de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, et al. Sarcomatoid differentiation in renal cell carcinoma: A study of 101 cases. Am J Surg Pathol 2001; 25:275-84; PMID:11224597; http://dx.doi.org/10.1097/00000478-200103000-00001
  • Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The international society of urological pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013; 37:1490-504; PMID:24025520; http://dx.doi.org/10.1097/PAS.0b013e318299f0fb
  • Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcomes and prognostic feature among histological subtypes of renal cell carcinoma. Am J Surg Pathol 2003; 27:612-24; PMID:12717246; http://dx.doi.org/10.1097/00000478-200305000-00005
  • Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds: World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon, France: IARC Press, 2004
  • Conant JL, Peng Z, Evans MF, Naud S, Cooper K. Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition. J Clin Pathol 2011; 64:1088-92; PMID:22003062; http://dx.doi.org/10.1136/jclinpath-2011-200216
  • Guarino M, Rubino B, Ballabio G. The role of ephitelial-mesenchymal transition in cancer pathology. Pathology 2007; 39:305-18; PMID:17558857; http://dx.doi.org/10.1080/00313020701329914
  • Tanas MR, Sthapanachai C, Nonaka D, Melamed J, Oliveira AM, Erickson-Johnson MR, et al. Pseudosarcomatous fibroblasticmyofibroblastic proliferation in perinephric adipose tissue adjacent to renal cell carcinoma: a lesion mimicking well-differentiated liposarcoma. Mod Pathol 2009; 22:1196-200; PMID:19525929; http://dx.doi.org/10.1038/modpathol.2009.84
  • Gadre SA, Math SK, Elfeel KA, Farghaly H. Cytology of a sarcomatoid renal cell carcinoma with unusual coexpression of S-100 protein: a case report, review of the literature and cytologic-histologic correlation. Diagn Cytopathol 2008; 37:195-8; http://dx.doi.org/10.1002/dc.21003
  • Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H. Review of sarcomatoid renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18:551-5; PMID:12647806
  • Escudier B, Droz JP, Rolland F, Terrier-Lacombe MJ, Gravis G, Beuzeboc P, et al. Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: A phase II study of the Genitourinary Group of the French Federation of Cancer Centers. J Urol 2002; 168:959-61; PMID:12187199; http://dx.doi.org/10.1016/S0022-5347(05)64551-X
  • Yap BS, Baker LH, Sinkovics JG, Rivkin SE, Bottomley R, Thigpen T, et al. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combinationchemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 1980; 64:93-8; PMID:7379060
  • Lupera H, Theodore C, Ghosn M, Court BH, Wibault P, Droz JP. Phase II trial of combination chemotherapy with dacarbazine, cyclophosphamide, cisplatin, doxorubicin, and vindesine (DECAV) in advanced renal cell cancer. Urology 1989; 34:281-3; PMID:2815451; http://dx.doi.org/10.1016/0090-4295(89)90326-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.